Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) - ANVISA Registration 10071770892

Access comprehensive regulatory information for ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10071770892 and manufactured by ABBOTT DIAGNOSTICS MEDICAL CO., LTD.. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Jun 04, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including QUIBASA QUÍMICA BÁSICA LTDA, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10071770892
2 Related Devices
Registration Details
ANVISA Registration Number: 10071770892
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Registration Details

10071770892

25351927542201684

50248780000161

Company Information

Japan
PT: JAPÃO

Dates and Status

Jun 04, 2018

04/06/2028

09/18/2025 19:00:01

Registration Details

10071770892

25351927542201684

50248780000161

Company Information

Dates and Status

Jun 04, 2018

04/06/2028

09/18/2025 19:00:01